I found all three sessions to be informative and it has changed my view of one of the three (I hold one but not the other two).
Personally, the RCE update was informative, the CYP update was also interesting but it perhaps spent a bit too much time focussed on a competitor.
The PXS session was not only informative, but it was also concise and the most articulately delivered. Looking forward to see the progress of all, but especially PXS.
GLTAH.
Ann: Pharmaxis to Present at Proactive CEO Investor Session, page-4
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
